Related Experiment Video
Updated: May 4, 2026
Subretinal Transplantation of MACS Purified Photoreceptor Precursor Cells into the Adult Mouse Retina
Published on: February 22, 2014
Human retinal progenitor cell transplantation preserves vision
Jing Luo1, Petr Baranov2, Sherrina Patel3
1Department of Ophthalmology, Second Xiangya Hospital and International Academy of Translational Medicine, Central South University, Changsha, Hunan 410011, China; Institute for Genomic Medicine and Shiley Eye Center, University of California at San Diego, La Jolla, California 92093.
Human retinal progenitor cells (hRPCs) show therapeutic potential for retinal degenerative diseases. Transplantation in rats preserved visual acuity and retinal structure, indicating a promising cell therapy for vision loss.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Background:
- Retinal degenerative diseases cause photoreceptor loss, necessitating new therapies.
- Cell transplantation offers potential but faces safety and cell supply challenges.
- Human retinal progenitor cells (hRPCs) are expandable and undifferentiated, making them suitable for transplantation.
Purpose of the Study:
- To evaluate the therapeutic efficacy of hRPC transplantation in a Royal College of Surgeons (RCS) rat model of retinal degeneration.
- To assess the safety and impact of hRPCs on visual function and retinal structure.
Main Methods:
- Transplantation of hRPCs into the subretinal space of RCS rats.
- Evaluation of visual acuity using optokinetic response at 12 weeks.
- Histological analysis of the outer nuclear layer (ONL) for thickness, spread, and cell count.
Main Results:
- hRPC-grafted eyes showed significantly improved visual acuity compared to controls.
- Histological analysis revealed significantly greater preservation of the ONL in hRPC-treated eyes.
- Transplanted hRPCs arrested visual decline and rescued retinal morphology without adverse effects like tumor formation.
Conclusions:
- hRPC transplantation is a safe and effective therapy for halting visual decline in a rat model of retinal degeneration.
- The study demonstrates the potential of hRPCs for treating photoreceptor loss in retinal degenerative diseases.
- Host photoreceptor rescue is the likely mechanism underlying the observed preservation of visual acuity.
